CR6261CR8020FLZ2001: Multicenter, randomized, double-blind, placebo-controlled study to evaluate the effect of CR8020 and CR6261 in hospitalized patients with influenza A infection

Project: Research project

Project Details

StatusFinished
Effective start/end date2/20/142/19/15

Funding

  • Crucell Holland B.V. (Invoice # SP0022556-01R)
  • National Institute of Allergy and Infectious Diseases (Invoice # SP0022556-01R)